CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Santis, M. L.
Right arrow Articles by Salomon, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Santis, M. L.
Right arrow Articles by Salomon, D. S.

Cell Growth & Differentiation, Vol 8, Issue 12 1257-1266, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway

ML De Santis, S Kannan, GH Smith, M Seno, C Bianco, N Kim, I Martinez-Lacaci, B Wallace-Jones and DS Salomon
Tumor Growth Factor Section, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein beta-casein. In contrast, simultaneous treatment of mouse HC-11 cells with CR-1 in the presence of DIP inhibited beta-casein expression. The inhibitory effects of CR-1 on beta-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because beta-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on beta-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21ras farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of beta-casein is mediated through a p21ras-dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC-11 cells.


This article has been cited by other articles:


Home page
J Biol ChemHome page
S. Shi, C. Ge, Y. Luo, X. Hou, R. S. Haltiwanger, and P. Stanley
The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling
J. Biol. Chem., July 13, 2007; 282(28): 20133 - 20141.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Chu, J. Ding, K. Jeays-Ward, S. M. Price, M. Placzek, and M. M. Shen
Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis
Development, December 15, 2005; 132(24): 5539 - 5551.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Strizzi, C. Bianco, A. Raafat, W. Abdallah, C. Chang, D. Raafat, M. Hirota, S. Hamada, Y. Sun, N. Normanno, et al.
Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo
J. Cell Sci., October 15, 2005; 118(20): 4633 - 4643.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. C. Gray, C. A. Harrison, and W. Vale
Cripto forms a complex with activin and type II activin receptors and can block activin signaling
PNAS, April 29, 2003; 100(9): 5193 - 5198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bianco, L. Strizzi, A. Rehman, N. Normanno, C. Wechselberger, Y. Sun, N. Khan, M. Hirota, H. Adkins, K. Williams, et al.
A Nodal- and ALK4-independent Signaling Pathway Activated by Cripto-1 through Glypican-1 and c-Src
Cancer Res., March 15, 2003; 63(6): 1192 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Bianco, H. B. Adkins, C. Wechselberger, M. Seno, N. Normanno, A. De Luca, Y. Sun, N. Khan, N. Kenney, A. Ebert, et al.
Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells
Mol. Cell. Biol., April 15, 2002; 22(8): 2586 - 2597.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
L. Shan, S. A. Rouhani, H. A. J. Schut, and E. G. Snyderwine
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Modulates Lactogenic Hormone-mediated Differentiation and Gene Expression in HC11 Mouse Mammary Epithelial Cells
Cell Growth Differ., December 1, 2001; 12(12): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. G. Schiffer, S. Foley, A. Kaffashan, X. Hronowski, A. E. Zichittella, C.-Y. Yeo, K. Miatkowski, H. B. Adkins, B. Damon, M. Whitman, et al.
Fucosylation of Cripto Is Required for Its Ability to Facilitate Nodal Signaling
J. Biol. Chem., October 12, 2001; 276(41): 37769 - 37778.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. K. Rowinsky, J. J. Windle, and D. D. Von Hoff
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
J. Clin. Oncol., November 1, 1999; 17(11): 3631 - 3652.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. D. Ebert, C. Wechselberger, S. Frank, B. Wallace-Jones, M. Seno, I. Martinez-Lacaci, C. Bianco, M. De Santis, H. K. Weitzel, and D. S. Salomon
Cripto-1 Induces Phosphatidylinositol 3'-Kinase-dependent Phosphorylation of AKT and Glycogen Synthase Kinase 3{beta} in Human Cervical Carcinoma Cells
Cancer Res., September 1, 1999; 59(18): 4502 - 4505.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Bianco, S. Kannan, M. De Santis, M. Seno, C. K. Tang, I. Martinez-Lacaci, N. Kim, B. Wallace-Jones, M. E. Lippman, A. D. Ebert, et al.
Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation oferb B-4 through a Novel Receptor
J. Biol. Chem., March 26, 1999; 274(13): 8624 - 8629.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. G. Schiffer, S. Foley, A. Kaffashan, X. Hronowski, A. Zichittella, C.-Y. Yeo, K. Miatkowski, H. B. Adkins, B. Damon, M. Whitman, et al.
Fucosylation of Cripto is required for its ability to facilitate Nodal signaling
J. Biol. Chem., August 9, 2001; (2001) 104774200.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.